X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1063) 1063
Book Review (129) 129
Publication (56) 56
Newsletter (46) 46
Book Chapter (7) 7
Magazine Article (3) 3
Conference Proceeding (2) 2
Government Document (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (913) 913
humans (735) 735
primaquine (685) 685
malaria (539) 539
male (462) 462
female (358) 358
primaquine - administration & dosage (347) 347
animals (346) 346
adult (317) 317
antimalarials - therapeutic use (300) 300
primaquine - therapeutic use (297) 297
antimalarials - administration & dosage (287) 287
infectious diseases (273) 273
tropical medicine (262) 262
parasitology (243) 243
parasitic diseases (235) 235
malaria, vivax - drug therapy (220) 220
research (219) 219
adolescent (200) 200
plasmodium vivax (197) 197
middle aged (192) 192
malaria - drug therapy (178) 178
child (177) 177
plasmodium falciparum (166) 166
chloroquine (164) 164
drug therapy, combination (152) 152
pharmacology & pharmacy (134) 134
drug therapy (131) 131
chloroquine - therapeutic use (130) 130
abridged index medicus (126) 126
infections (126) 126
chloroquine - administration & dosage (125) 125
child, preschool (122) 122
dosage and administration (122) 122
primaquine - pharmacology (121) 121
young adult (121) 121
antimalarials - pharmacology (119) 119
treatment outcome (119) 119
malaria, falciparum - drug therapy (118) 118
drug resistance (116) 116
parasites (114) 114
drugs (113) 113
antimalarials - adverse effects (110) 110
primaquine - adverse effects (108) 108
public, environmental & occupational health (108) 108
vector-borne diseases (104) 104
plasmodium falciparum - drug effects (100) 100
recurrence (98) 98
aged (96) 96
health aspects (96) 96
drug dosages (95) 95
mice (95) 95
malaria - prevention & control (92) 92
plasmodium vivax - drug effects (91) 91
analysis (90) 90
transmission (90) 90
antimalarials (89) 89
medicine (86) 86
public health (83) 83
infant (82) 82
medicine, general & internal (82) 82
phosphates (78) 78
care and treatment (77) 77
efficacy (77) 77
falciparum (77) 77
arctic medicine. tropical medicine (76) 76
microbiology (76) 76
artemisinins - therapeutic use (75) 75
drug administration schedule (75) 75
g6pd deficiency (75) 75
drug combinations (72) 72
resistance (72) 72
prevention (71) 71
medical research (70) 70
research article (70) 70
erythrocytes (69) 69
malaria, vivax - prevention & control (69) 69
blood (67) 67
infectious and parasitic diseases (67) 67
malaria, vivax - epidemiology (67) 67
artemisinins - administration & dosage (66) 66
prophylaxis (66) 66
pharmacokinetics (65) 65
relapse (65) 65
children (64) 64
dehydrogenases (64) 64
antimalarials - pharmacokinetics (63) 63
vivax malaria (63) 63
anemia (62) 62
glucose (61) 61
glucosephosphate dehydrogenase (61) 61
therapy (60) 60
epidemiology (59) 59
disease transmission (57) 57
dose-response relationship, drug (57) 57
malaria, vivax - parasitology (57) 57
rats (57) 57
clinical trials (54) 54
plasmodium-vivax (54) 54
primaquine - pharmacokinetics (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1056) 1056
Chinese (15) 15
Spanish (11) 11
Portuguese (9) 9
French (6) 6
German (6) 6
Japanese (5) 5
Russian (5) 5
Italian (2) 2
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Landier, Jordi and Parker, Daniel M and Thu, Aung Myint and Lwin, Khine Shwe War and Lwin, Khin Maung and Delmas, Gilles and Nosten, Suphak and Nosten, François H and Andolina, Chiara and Aguas, Ricardo and Ang, Saw Moe and Aung, Ei Phyo and Baw, Naw Baw and Be, Saw Aye and B'Let, Saw and Bluh, Hay and Bonnington, Craig A and Chaumeau, Victor and Chirakiratinant, Miasa and Cho, Win Cho and Christensen, Peter and Corbel, Vincent and Day, Nicholas PJ and Dah, Saw Hsa and Dhorda, Mehul and Dondorp, Arjen M and Gaudart, Jean and Gornsawun, Gornpan and Haohankhunnatham, Warat and Hla, Saw Kyaw and Hsel, Saw Nay and Htoo, Gay Nay and Htoo, Saw Nay and Imwong, Mallika and John, Saw and Kajeechiwa, Ladda and Kereecharoen, Lily and Kittiphanakun, Praphan and Kittitawee, Keerati and Konghahong, Kamonchanok and Khin, Saw Diamond and Kyaw, Saw Win and Ling, Clare and Ma, Naw K' Yin and Marie, Alexandra and Maung, Cynthia and Marta, Ed and Minh, Myo Chit and Miotto, Olivo and Moo, Paw Khu and Moo, Merry and Moo, Ku Ler and Na, Naw Na and Nay, Mar and Nyo, Slight Naw and Oh, Eh Kalu Shwe and Oo, Tun Pyit and Oo, Phu Thit and Paw, Eh Shee and Phumiya, Choochai and Phyo, Aung Pyae and Pilaseng, Kasiha and Proux, Stéphane and Rakthinthong, Santisuk and Ritwongsakul, Wannee and Salathibuphha, Kloloi and Santirad, Armon and Sawasdichai, Sunisa and von Seidlein, Lorenz and Shee, Paw Bway and Shee, Paw Wah and Tangseefa, Decha and Thwin, May Myo and Tun, Saw Win and Wanachaloemlep, Chode and White, Lisa J and White, Nicholas J and Wiladphaingern, Jacher and Win, Saw Nyunt and Yee, Nan Lin and Yuwapan, Daraporn and Malaria Elimination Task Force Grp and Malaria Elimination Task Force Group
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
Potentially untreatable malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested... 
RESISTANCE | MEDICINE, GENERAL & INTERNAL | AREA | SPREAD | EPIDEMIOLOGY | Prevalence | State Medicine | Artemether, Lumefantrine Drug Combination | Humans | Fluorenes - therapeutic use | Male | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Incidence | Rural Population | Malaria, Falciparum - diagnosis | Malaria, Falciparum - epidemiology | Female | Fluorenes - administration & dosage | Drug Resistance | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Mass Drug Administration - methods | Primaquine - therapeutic use | Myanmar - epidemiology | Ethanolamines - therapeutic use | Early Diagnosis | Drug Combinations | Plasmodium falciparum | Diagnosis | Malaria | Analysis | Intervention | Dihydroartemisinin | Vector-borne diseases | Medical research | Primaquine | Hot spots | Artemisinin | Parasites | Dosage | Medical diagnosis | Molecular chains | Surveys | Charities | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Villages | Artemether | Histocompatibility antigen HLA | Adults | Diagnostic systems | Genotypes | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
BMC Medicine, ISSN 1741-7015, 12/2018, Volume 16, Issue 1, pp. 215 - 215
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2018, Volume 128, Issue 4, pp. 1551 - 1562
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 10/2019, Volume 44, Issue 5, pp. 800 - 804
In this rare case report, a patient with mantle cell lymphoma (MCL) with CNS dissemination was treated with several cycles of high‐dose methotrexate (HD‐MTX).... 
CNS dissemination | primaquine | drug interaction | safety | clinical pharmacokinetics | pharmacokinetics | mantle cell lymphoma | methotrexate | hematologic malignancy | therapeutic drug monitoring | Medical examination | Primaquine | Analysis | Drug interactions | Lymphomas | Methotrexate | Blood | Side effects | Mantle cell lymphoma | Pharmacokinetics | Mantle | Lymphoma
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 03/2015, Volume 15, Issue 1, pp. 144 - 144
Background: Antimalarial drugs are a powerful tool for malaria control and elimination. Artemisinin-based combination therapies (ACTs) can reduce transmission... 
VIVAX MALARIA | INFECTIOUS DISEASES | TRANSMISSION | POPULATION PHARMACOKINETICS | DIHYDROARTEMISININ-PIPERAQUINE | NON-INFERIORITY TRIAL | DOUBLE-BLIND | UNCOMPLICATED FALCIPARUM | THERAPEUTIC RESPONSE | PLASMODIUM-FALCIPARUM MALARIA | CLUSTER-RANDOMIZED TRIAL | Malaria, Falciparum - prevention & control | Prevalence | Artemisinins - pharmacokinetics | Humans | Middle Aged | Fluorenes - therapeutic use | Child, Preschool | Infant | Male | Quinolines - administration & dosage | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Malaria, Falciparum - transmission | Ethanolamines - pharmacokinetics | Malaria, Falciparum - epidemiology | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Zambia - epidemiology | Drug Therapy, Combination | Child | Fluorenes - pharmacokinetics | Antimalarials - pharmacokinetics | Primaquine - pharmacokinetics | Post-Exposure Prophylaxis - methods | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Models, Biological | Primaquine - therapeutic use | Adolescent | Ethanolamines - therapeutic use | Aged | Quinolines - therapeutic use | Drug Combinations | Antimalarials | Control | Malaria | Drug therapy | Primaquine | Health aspects | Usage | Disease transmission | Medical screening | Comparative analysis | Index Medicus | Quantitative Biology - Populations and Evolution
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2016, Volume 71, Issue 9, pp. 2405 - 2413
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2014, Volume 177, Issue 1, pp. 84 - 95
Journal Article
Malaria Journal, ISSN 1475-2875, 2011, Volume 10, Issue 1, pp. 212 - 212
Background: Tafenoquine is an 8-aminoquinoline being developed for radical cure (blood and liver stage elimination) of Plasmodium vivax. During monotherapy... 
VIVAX MALARIA | RELAPSE | ANTIMALARIAL-DRUGS | WR-238605 | FALCIPARUM-MALARIA | PHARMACOKINETICS | CHLOROQUINE | PRIMAQUINE | PARASITOLOGY | TROPICAL MEDICINE | BLOOD | Quinine - pharmacokinetics | Artemisinins - pharmacokinetics | Humans | Aminoquinolines - administration & dosage | Male | Ethanolamines - administration & dosage | Ethanolamines - pharmacokinetics | Mass Spectrometry | Mefloquine - administration & dosage | Mefloquine - pharmacokinetics | Chromatography, Liquid | Fluorenes - administration & dosage | Plasmodium cynomolgi | Disease Models, Animal | Fluorenes - pharmacokinetics | Antimalarials - pharmacokinetics | Artemisinins - administration & dosage | Treatment Outcome | Macaca mulatta - parasitology | Drug Therapy, Combination - methods | Animals | Antimalarials - administration & dosage | Plasma - chemistry | Primate Diseases - drug therapy | Quinine - administration & dosage | Chloroquine - administration & dosage | Aminoquinolines - pharmacokinetics | Malaria - drug therapy | Chloroquine - pharmacokinetics | Drug Combinations | Tafenoquine | Complications and side effects | Plasmodium | Malaria | Causes of | Physiological aspects | Dosage and administration | Research | Drug therapy | Drugs | Phosphates | Mefloquine | Toxicity | Liver | Chloroquine | Cohorts | Parasites | Monkeys & apes | Quinine | Blood | Fever | Glucose dehydrogenase | Armed forces | Artemether | Laboratory animals | Glucosephosphate dehydrogenase | Drug dosages | Public health | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1762 - 1768
Journal Article